NIH-funded research NIH-funded research

Sepsis-related DNA changes that may cause long-term immune weakness

Official title: Analyzing the long-term effects of DNA methylation meditated immunosuppression following sepsis

Funded at Ohio State University · NIH-11160639 · Data updated 2026-11-12

This research looks at whether changes to DNA after sepsis lead to lasting immune weakness in people who survive sepsis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startSeptember 10, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$393,750
NIH project number5R35GM150968-03
Project IDNIH-11160639 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults who survived sepsis (especially surgical sepsis), can provide blood samples, and are willing to attend follow-up visits and share health information.

Less likely to help

People without a history of sepsis or those unable to give blood or attend follow-up visits are unlikely to benefit from participation.

What this research studies

If you join, researchers will collect blood samples and medical information from people who survived sepsis to measure DNA methylation and related enzyme activity. They will compare immune system function and rates of new infections, physical decline, and mood problems over time. The team will link molecular findings (like increased DNA methyltransferase activity) to clinical and psychosocial outcomes to understand how epigenetic changes affect recovery. This work combines lab-based measurements with patient follow-up to find patterns that explain long-term problems after sepsis.

Why it matters

Potential benefit: If successful, this work may identify biological markers and pathways that explain persistent immune problems after sepsis and point to ways to restore immune health.

How similar studies have gone: Previous studies and the investigator's preliminary data show DNA methylation changes and increased DNMT activity after sepsis, but translating these findings into ways to help patients is still novel and developing.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Wisler, Jon R — Ohio State University
  • Study coordinator: Wisler, Jon R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.